Biogen licenses a possible immune drug from OrbiMed-backed biotech
Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical immune drug from Vanqua Bio, a biotech company backed by OrbiMed, in a deal worth over $1 billion. The …
Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical immune drug from Vanqua Bio, a biotech company backed by OrbiMed, in a deal worth over $1 billion. The …
Interview with Rupert Bedell, Managing Director at Fasthosts Fasthosts is a long-standing, award-winning internet hosting business based i…
FreeAgent, a provider of accounting software, has announced a new partnership with Pleo, a smart spend management platform, to simplify day-to-day …
Tijuana Xolos Road Struggles Continue The Tijuana Xolos suffered a 4-3 loss to Puebla, marking their second consecutive loss away from hom…
Lutheran North Finishes Top 10 at State Finals Macomb Lutheran North finished in the top 10 at the Lower Peninsula Division 3 state finals…
Brazil Shifts Air Operations Closer to Venezuela Open-source intelligence analysts have observed unusual flight activity involving severa…
Red Bull's RB21 Upgrade Progress Red Bull's chief engineer, Paul Monaghan, believes the team has gained control over the "complete behavio…
Supermicro's Quarterly Sales and Future Outlook Supermicro reported lower quarterly sales due to shipment delays and customer upgrades.
Kylie Minogue Announces New Festive Album Kylie Minogue has revealed her upcoming album Kylie Christmas (Fully Wrapped), schedul…